No abstract available
Keywords:
anticoagulation; atrial fibrillation; bioprosthetic valve; edoxaban; warfarin.
Publication types
-
Letter
-
Multicenter Study
-
Randomized Controlled Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anticoagulants / administration & dosage*
-
Anticoagulants / adverse effects
-
Atrial Fibrillation / blood
-
Atrial Fibrillation / complications
-
Atrial Fibrillation / diagnosis
-
Atrial Fibrillation / drug therapy*
-
Bioprosthesis* / adverse effects
-
Blood Coagulation / drug effects
-
Factor Xa Inhibitors / administration & dosage*
-
Factor Xa Inhibitors / adverse effects
-
Heart Valve Prosthesis Implantation / adverse effects
-
Heart Valve Prosthesis Implantation / instrumentation*
-
Heart Valve Prosthesis* / adverse effects
-
Hemorrhage / chemically induced
-
Humans
-
Pyridines / administration & dosage*
-
Pyridines / adverse effects
-
Risk Factors
-
Stroke / blood
-
Stroke / diagnosis
-
Stroke / etiology
-
Stroke / prevention & control*
-
Thiazoles / administration & dosage*
-
Thiazoles / adverse effects
-
Thromboembolism / blood
-
Thromboembolism / diagnosis
-
Thromboembolism / etiology
-
Thromboembolism / prevention & control*
-
Treatment Outcome
-
Warfarin / administration & dosage*
-
Warfarin / adverse effects
Substances
-
Anticoagulants
-
Factor Xa Inhibitors
-
Pyridines
-
Thiazoles
-
Warfarin
-
edoxaban